Hidradenitis Suppurativa Study of Izokibep

NCT05905783 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

258

Enrollment

INDUSTRY

Sponsor class

Stopped Per our 13Aug24 press release, we announced discontinuation of internal development in this indication. This decision was not due to safety reasons.

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: Placebo
DRUG: Izokibep

Sponsor

ACELYRIN Inc.